News and Trends 23 Mar 2023
Flare Therapeutics sees $123M oncology boost
Flare Therapeutics Inc., a biotechnology company targeting transcription factors to discover precision medicines for cancer and other diseases, has announced a $123 million Series B financing. The financing was co-led…